Historical record - last NADAC effective date: 8/19/2020
Product Information
LIDOCAINE HCL 4% CREAM is a generic product labeled by Rugby Laboratories, priced at $0.7794 per GM under NDC 00536113920. Its NADAC has been published 100 times since Sep 18, 2019.
Strength
40 mg/g
Manufacturer
Rugby LaboratoriesNDC
00536113920
Classification
Generic
Dosage Form
CREAM
Route
TOPICAL
Effective Date
8/19/2020
Active Ingredients
LIDOCAINE HYDROCHLORIDEApproval Type
OTC MONOGRAPH DRUG
FDA Application
M017On Market Since
9/21/2018
Pharmacological Classes
Price Statistics
The NADAC for LIDOCAINE HCL 4% CREAM has been published 100 times since Sep 18, 2019, and over the history we have for it it has risen 10.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.7794 per GM |
|---|---|
| All-time high | $0.7794 (Aug 11, 2021) |
| All-time low | $0.7043 (Sep 18, 2019) |
| Median price | $0.7794 |
| Average price | $0.7434 |
| Largest weekly change | +10.7% (Aug 19, 2020) |
| Weeks tracked | 100 |
| Tracking since | Sep 18, 2019 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
N/A
All
+10.7%
Last surveyed Aug 11, 2021 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 37% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Rugby Laboratories manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Lidocaine market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Amide Local Anesthetic class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of LIDOCAINE HCL 4% CREAM?
The current National Average Drug Acquisition Cost (NADAC) for LIDOCAINE HCL 4% CREAM, manufactured by Rugby Laboratories, is $0.7794 per GM (NDC 00536113920), effective Aug 11, 2021.
How has the price of LIDOCAINE HCL 4% CREAM changed over time?
Over the history we have for it, the NADAC for LIDOCAINE HCL 4% CREAM has risen 10.7%. It has been tracked across 100 weekly CMS publications since Sep 18, 2019.
What are the highest and lowest recorded NADAC prices for LIDOCAINE HCL 4% CREAM?
Since Sep 18, 2019, the NADAC for LIDOCAINE HCL 4% CREAM has ranged from a low of $0.7043 (Sep 18, 2019) to a high of $0.7794 (Aug 11, 2021), with a median of $0.7794 per GM.
Are there cheaper alternatives to LIDOCAINE HCL 4% CREAM?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, LIDOCAINE 4% CREAM, is $0.4899 per GM — about 37% below LIDOCAINE HCL 4% CREAM.
Who manufactures LIDOCAINE HCL 4% CREAM?
LIDOCAINE HCL 4% CREAM (NDC 00536113920) is labeled by Rugby Laboratories, and CMS classifies it as a generic product.